In theory, lipids should be easy to produce on a large scale, but it gets complicated when the goal is to produce billions of new COVID-19 vaccines for the world.
Vaccine makers face possible strain on supply of key ingredient: lipid molecules
In theory, lipids should be easy to produce on a large scale, but it gets complicated when the goal is to produce billions of new COVID-19 vaccines for the world.